Not yet recruiting
Type 2 diabetes mellitus
Not yet recruitingEvaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
Registered drugNo placebo
Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults
Registered drugNo placebo
- Disease:Type 2 diabetes mellitus
- Substances:AlbiglutideAlogliptin+14
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Substances:Albiglutide
